EUVIMEDEUVIMED entdecken
EUVIMED · CrossrefZeitschrift

The Oncologist

ISSN 1083-7159 · Oxford University Press (OUP)

Neueste Artikel

  1. Cholesterol transporters and immune-metabolic features in patients with metastatic renal cell carcinoma receiving immunotherapy combinations

    Giulia Claire Giudice, Hassan Mohammed Abushukair, Giulia Mazzaschi, Pietro Tuttobene, Michele Maffezzoli, Letizia Gnetti, Nicoletta Campanini, Giacomo Iovane, Fabiana Perrone, Monica Pluchino, Elena Rapacchi, Giada Pinterpe, Stefano Travaglini, Rosedwige Marchitelli, Tae Gyu Oh, Abdul Rafeh Naqash, Matteo Santoni, Elisa Araldi, Roberto Pili, Riccardo Perrone, Francesco Potì, Rossana Berardi, Federica Pecci, Sebastiano Buti

    Erschienen: 2026-11-06DOI: 10.1093/oncolo/oyag430

  2. Tumor Longevity: a time-dependent biomarker of immune checkpoint inhibitor responsiveness across head and neck, lung, renal and urothelial cancers

    Rebecca Romanò, Chiara Airoldi, Salvatore Alfieri, Anna Piemontese, Silvia Pierri, Gabriele Calvanese, Daniele Piscazzi, Gabriele Ciarlo, Diego Signorelli, Elio Gregory Pizzutilo, Giulio Cerea, Laura Giannetta, Annalisa Zeppellini, Giorgio Patelli, Silvia Buriolla, Simone Rota, Federica Manoni, Noemi Crippa, Cecilia Silvestri, Simone Oldani, Sabina Sangaletti, Rosalba Miceli, Andrea Sartore-Bianchi, Salvatore Siena, Lisa Licitra

    Erschienen: 2026-11-06DOI: 10.1093/oncolo/oyag445

  3. A phase 2 study of tipifarnib in children and young adults with tumors harboring HRAS genomic alterations: NCI-COG Pediatric MATCH trial (APEC1621M)

    Christine A Pratilas, Marielle E Yohe, Paul M Williams, Joel M Reid, Jin Piao, Lauren Saguilig, David R Patton, Brent Coffey, Todd A Alonzo, Alexandria M Thompson, Nicole Arwood, Sinchita Roy-Chowdhuri, Nilsa C Ramirez, Stacey L Berg, Elizabeth Fox, Brenda J Weigel, Douglas S Hawkins, Margaret M Mooney, Naoko Takebe, James V Tricoli, Katherine A Janeway, Nita L Seibel, Donald W Parsons

    Erschienen: 2026-11-05DOI: 10.1093/oncolo/oyag401

  4. Site-specific outcomes and genomics in metastatic pancreatic ductal adenocarcinoma

    Mahmoud Yousef, Saikat Chowdhury, Sali Albarouki, Ahmed Elhariri, Guglielmo Vetere, Sacha El Khoury, Mohammad Fanaeian, Abdelrahman Yousef, Ashwathy Balachandran Pillai, Kristin Alfaro-Munoz, Mark Knafl, Paul Roy, Mark W Hurd, Brandon G Smaglo, Robert A Wolff, Shubham Pant, Jason Willis, Ryan Huey, Michael J Overman, Camila Lopez, Anthony Chen, Ethan B Ludmir, Eugene J Koay, Rebecca A Snyder, Ching-Wei Tzeng, Michael P Kim, Naruhiko Ikoma, Jessica E Maxwell, Huamin Wang, Anirban Maitra, Matthew H G Katz, Yang Chen, Haoqiang Ying, John Paul Shen, Dan Zhao

    Erschienen: 2026-11-05DOI: 10.1093/oncolo/oyag423

  5. Immunotherapy and cancer: the CIPOMO viewpoint on challenges and opportunities

    Giuseppe Aprile, Donatella Iacono, Sandro Barni, Monica Giordano, Cinzia Ortega, Rosa Rita Silva, Paolo Tralongo, Luisa Fioretto, Giuseppe Aprile, Monica Giordano, Cinzia Ortega, Rosa Rita Silva, Giovanni Pietro Ianniello, Katia Cannita, Clementina Savastano, Antonio Iaria, Fabrizio Artioli, Alessandro Follador, Teresa Gamucci, Carlo Aschele, Andrea De Monte, Renato Bisonni, Roberta Buosi, Silvana Leo, Maria Giuseppina Sarobba, Stefano Vitello, Angela Stefania Ribecco, Orazio Caffo, Riccardo Rossetti, Teodoro Sava, Luigi Cavanna, Alberto Scanni, Luisa Fioretto

    Erschienen: 2026-11-04DOI: 10.1093/oncolo/oyag435

  6. Whole-genome sequencing-based tumor-informed circulating tumor DNA monitoring for early detection of recurrence in patients with solid tumors

    Mridula George, Gary S Schwartz, Wassim McHayleh, Vitaly Margulis, Hideaki Bando, Takayuki Yoshino, George Ansstas, Carly Bess Scalise, Sumedha Sudhaman, Arkarachai Fungtammasan, Bharat Sridhar, Jordan Feeney, Himanshu Sethi, Morgan M Quail, Sharlene Velichko, Wilson Tan, Alexander Hsieh, Anastasia Butskova, Ryan Ptashkin, Carcia Carson, Ashley Wray, Charuta C Palsuledesai, Meenakshi Malhotra, Ahmet Zehir, Eser Kirkizlar, Matthew Rabinowitz, Ryan K Swenerton, Gabrielle Heilek, Adham Jurdi, Adam C ElNaggar, Michael Krainock, Caitlin A Schonewolf, Angel A Rodriguez, Shruti Sharma, Ekaterina Kalashnikova, Minetta C Liu, Alexey Aleshin, Matthew D Galsky

    Erschienen: 2026-10-07DOI: 10.1093/oncolo/oyag404

  7. Long-term efficacy, clinical outcomes, and safety of vimseltinib in patients with tenosynovial giant cell tumor: results from the MOTION phase 3 trial

    Vivek Bhadri, Hans Gelderblom, Silvia Stacchiotti, Sebastian Bauer, Andrew J Wagner, Michiel van de Sande, Nicholas M Bernthal, Antonio López Pousa, Albiruni Abdul Razak, Antoine Italiano, Mahbubl Ahmed, Axel Le Cesne, Gabriel Tinoco, Kjetil Boye, Javier Martín-Broto, Emanuela Palmerini, Salvatore Tafuto, Sarah Pratap, Benjamin C Powers, Peter Reichardt, Antonio Casado Herráez, Piotr Rutkowski, Christopher Tait, Giulia Agnello, Brooke Harrow, Amanda Saunders, Maitreyi G Sharma, Matthew L Sherman, Jean-Yves Blay, William D Tap

    Erschienen: 2026-10-07DOI: 10.1093/oncolo/oyag421

Jahrgänge

2026 · 3872025 · 6742024 · 4062023 · 3272022 · 2862021 · 4652020 · 4482019 · 4152018 · 2592017 · 2392016 · 2342015 · 2602014 · 2162013 · 2492012 · 2542011 · 2552010 · 2082009 · 1752008 · 1952007 · 1902006 · 1582005 · 1392004 · 1292003 · 1152002 · 1622001 · 1512000 · 1151999 · 691998 · 681997 · 861996 · 70

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.